Mutation studies have shown the occurrence and severity of TSC-associated renal angiomyolipomas and cysts to be higher among patients with TSC2 mutation than those with TSC1 mutation (8, 17). This evidence concerns the gene TSC1 and kidney angiomyolipoma.